Primecap Management CO Rhythm Pharmaceuticals, Inc. Transaction History

Primecap Management CO

$132 Billion
Q1 2024

A detailed history of Primecap Management CO transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Primecap Management CO holds 7,747,591 shares of RYTM stock, worth $318 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

7,747,591

Previous 8,052,648 3.79%

Holding current value

$318 Million

Previous $370 Million 9.31%

% of portfolio

0.25%

Previous 0.3%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$39.12 - $52.44 $11.9 Million - $16 Million	-305,057 Reduced 3.79%	7,747,591 $336 Million
Q4 2023 Feb 09, 2024	SELL	$21.39 - $49.64 $4.59 Million - $10.7 Million	-214,773 Reduced 2.6%	8,052,648 $370 Million
Q3 2023 Nov 13, 2023	SELL	$15.81 - $27.8 $504,275 - $886,708	-31,896 Reduced 0.38%	8,267,421 $189 Million
Q2 2023 Aug 11, 2023	BUY	$16.32 - $21.15 $11.3 Million - $14.6 Million	692,006 Added 9.1%	8,299,317 $137 Million
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $11.8 Million - $23.8 Million	696,169 Added 10.07%	7,607,311 $136 Million

Q4 2022 Feb 13, 2023	SELL	$22.25 - $30.25 $2.58 Million - $3.5 Million	-115,750 Reduced 1.65%	6,911,142 $201 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $2.85 Million - $20.4 Million	662,798 Added 10.41%	7,026,892 $172 Million
Q2 2022 Aug 11, 2022	BUY	$3.12 - $12.25 $224,961 - $883,261	72,103 Added 1.15%	6,364,094 $26.4 Million
Q1 2022 May 11, 2022	BUY	$6.13 - $12.24 $214,550 - $428,400	35,000 Added 0.56%	6,291,991 $72.5 Million
Q4 2021 Feb 11, 2022	BUY	$8.62 - $13.9 $654,257 - $1.06 Million	75,900 Added 1.23%	6,256,991 $62.4 Million
Q3 2021 Nov 12, 2021	BUY	$11.68 - $20.72 $320,032 - $567,728	27,400 Added 0.45%	6,181,091 $80.7 Million
Q2 2021 Aug 10, 2021	BUY	$18.52 - $22.55 $2.74 Million - $3.34 Million	148,098 Added 2.47%	6,153,691 $120 Million
Q1 2021 May 14, 2021	BUY	$20.25 - $39.49 $33.7 Million - $65.7 Million	1,663,102 Added 38.3%	6,005,593 $128 Million
Q4 2020 Feb 08, 2021	BUY	$21.17 - $32.61 $16.3 Million - $25 Million	767,800 Added 21.48%	4,342,491 $129 Million
Q3 2020 Nov 13, 2020	BUY	$18.13 - $30.61 $542,087 - $915,239	29,900 Added 0.84%	3,574,691 $77.5 Million
Q2 2020 Aug 13, 2020	BUY	$14.41 - $25.35 $31,702 - $55,770	2,200 Added 0.06%	3,544,791 $79 Million
Q1 2020 May 14, 2020	BUY	$13.16 - $22.9 $19.1 Million - $33.2 Million	1,448,900 Added 69.2%	3,542,591 $53.9 Million
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $36.1 Million - $47.1 Million	1,846,714 Added 747.73%	2,093,691 $48.1 Million
Q3 2019 Nov 13, 2019	BUY	$18.62 - $24.51 $4.6 Million - $6.05 Million	246,977 New	246,977 $5.33 Million

Others Institutions Holding RYTM

# of Institutions

176

Shares Held

62.4M

Call Options Held

880K

Put Options Held

84.1K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.29B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Rhythm Pharmaceuticals, Inc. Transaction History